Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | FBXW7 |
| Variant | R505C |
| Impact List | missense |
| Protein Effect | loss of function |
| Gene Variant Descriptions | FBXW7 R505C lies within WD repeat 4 of the Fbxw7 protein (UniProt.org). R505C results in ubiquitination and degradation of Braf similar to wild-type Fbxw7 in cultured cells (PMID: 32907612), but confers a loss of function to Fbxw7 as indicated by a loss of binding to NICD in cell culture (PMID: 17646409), impaired degradation of NICD, resulting in increased activity in a luciferase assay (PMID: 27247421), failure to degrade cyclin E, c-Myc, and Mcl1 in cell culture (PMID: 32907612), aberrant subnuclear localization (PMID: 30510140), and impaired degradation of Klf5 in cell culture (PMID: 28963353). |
| Associated Drug Resistance | |
| Category Variants Paths |
FBXW7 mutant FBXW7 inact mut FBXW7 R505C |
| Transcript | NM_001349798.2 |
| gDNA | chr4:g.152326137G>A |
| cDNA | c.1513C>T |
| Protein | p.R505C |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| XM_047415897.1 | chr4:g.152326137G>A | c.1513C>T | p.R505C | RefSeq | GRCh38/hg38 |
| XM_011532084.3 | chr4:g.152326137G>A | c.1513C>T | p.R505C | RefSeq | GRCh38/hg38 |
| NM_033632.3 | chr4:g.152326137G>A | c.1513C>T | p.R505C | RefSeq | GRCh38/hg38 |
| NM_001349798.1 | chr4:g.152326137G>A | c.1513C>T | p.R505C | RefSeq | GRCh38/hg38 |
| XM_011532084.2 | chr4:g.152326137G>A | c.1513C>T | p.R505C | RefSeq | GRCh38/hg38 |
| XM_017008362 | chr4:g.152326137G>A | c.1513C>T | p.R505C | RefSeq | GRCh38/hg38 |
| XM_011532084 | chr4:g.152326137G>A | c.1513C>T | p.R505C | RefSeq | GRCh38/hg38 |
| NM_001349798.2 | chr4:g.152326137G>A | c.1513C>T | p.R505C | RefSeq | GRCh38/hg38 |
| XM_047415901.1 | chr4:g.152326137G>A | c.1513C>T | p.R505C | RefSeq | GRCh38/hg38 |
| XM_047415899.1 | chr4:g.152326137G>A | c.1513C>T | p.R505C | RefSeq | GRCh38/hg38 |
| XM_011532085.2 | chr4:g.152326137G>A | c.1513C>T | p.R505C | RefSeq | GRCh38/hg38 |
| XM_011532085 | chr4:g.152326137G>A | c.1513C>T | p.R505C | RefSeq | GRCh38/hg38 |
| XM_024454123.1 | chr4:g.152326137G>A | c.1513C>T | p.R505C | RefSeq | GRCh38/hg38 |
| XM_024454121.1 | chr4:g.152326137G>A | c.1513C>T | p.R505C | RefSeq | GRCh38/hg38 |
| XM_024454122.1 | chr4:g.152326137G>A | c.1513C>T | p.R505C | RefSeq | GRCh38/hg38 |
| XM_011532085.3 | chr4:g.152326137G>A | c.1513C>T | p.R505C | RefSeq | GRCh38/hg38 |
| XM_024454123.2 | chr4:g.152326137G>A | c.1513C>T | p.R505C | RefSeq | GRCh38/hg38 |
| XM_011532083 | chr4:g.152326137G>A | c.1513C>T | p.R505C | RefSeq | GRCh38/hg38 |
| NM_033632 | chr4:g.152326137G>A | c.1513C>T | p.R505C | RefSeq | GRCh38/hg38 |
| XM_024454124.1 | chr4:g.152326137G>A | c.1513C>T | p.R505C | RefSeq | GRCh38/hg38 |
| NM_033632.3 | chr4:g.152326137G>A | c.1513C>T | p.R505C | RefSeq | GRCh38/hg38 |
| XM_047415900.1 | chr4:g.152326137G>A | c.1513C>T | p.R505C | RefSeq | GRCh38/hg38 |
| XM_047415898.1 | chr4:g.152326137G>A | c.1513C>T | p.R505C | RefSeq | GRCh38/hg38 |
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|